Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleSpecial Contribution

Variations in PET/CT Methodology for Oncologic Imaging at U.S. Academic Medical Centers: An Imaging Response Assessment Team Survey

Michael M. Graham, Ramsey D. Badawi and Richard L. Wahl
Journal of Nuclear Medicine February 2011, 52 (2) 311-317; DOI: https://doi.org/10.2967/jnumed.109.074104
Michael M. Graham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramsey D. Badawi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    The complete survey: page 1.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    The complete survey: page 2.

Tables

  • Figures
    • View popup
    TABLE 1.

    Summary of Survey Questions

    CategoryQuestion
    Patient dose and preparation1. Administered dose of 18F-FDG:
    2. Uptake period in minutes:
    3. Is CT contrast used during the transmission scan?
    4. Fraction of patients who have a separate diagnostic CT acquisition:
    5. How often bladder catheterization is performed:
    6. How often sedation is used:
    7. Percentage of cases with intravenous contrast:
    8. Minimum duration of fasting before 18F-FDG injection:
    9. Is a low-carbohydrate diet recommended one or more days before PET study?
    10. Estimated frequency of different strategies used for preparation of diabetic patients:
    11. Is the blood glucose measured before 18F-FDG injection?
    12. Blood glucose cutoff:
    Scanner, acquisition, and reconstruction parameters13. PET scanner manufacturer and model: 14. PET scanner software version number:
    15. Emission scan acquisition mode (2D vs. 3D for whole body and brain):
    16. Scan extent (top of head to toes, base of brain to thighs, arms up, arms down, etc.):
    17. For whole-body scan, duration of emission scan per bed position:
    18. Nature of transmission scan (CT, 68Ge rod source, 133Cs):
    Display, review, and archiving19. CT technique used for the average adult patient:
    20. PET reconstruction algorithm used:
    21. Postreconstruction filter(s) used for reconstruction:
    22. PET voxel dimensions:
    23. Software used for image interpretation by radiologist/nuclear medicine physician:
    24. Are PET/CT images archived to PACS and available for viewing?
    25. Can PET/CT images on PACs be viewed as fused images?
    26. Quality of PACS PET/CT image display capability:
    27. Name of PACS software used by referring physicians for PET/CT:
    28. Do you make digital images available on compact disk for referring physicians or patients?
    29. Type of display software included on the compact disks you provide:
    30. Procedure for reviewing outside images:
    • View popup
    TABLE 2.

    Comparison of IRAT Survey Results with Recommendations of NCI, European Group, and ACRIN

    ParameterNCIEuropean groupACRINIRAT survey
    Administered dose370–740 MBq (10–20 mCi)5 mBq/kg for 2D, 2.5 MBq for 3D (370 MBq [10 mCi] for 2D, 185 MBq [5 mCi] for 3D for 70-kg patient)Dose is specific to each trial259–740 MBq (7–20 mCi)
    Uptake time50–70 min55–65 min50–70 min45–90 min
    Duration of fastingMinimum of 4 h4 h, prefer 6Minimum of 4 h4 or 6 h (evenly split)
    Recommendation for low-carbohydrate dietRecommend for 24 h beforeNot mentionedRecommend for 24 h beforeHalf the sites recommend
    Blood glucose cutoff<120 mg/dL for nondiabetic patients; 150–200 mg/dL for diabetic patientsReschedule if more than 126 mg/dLReschedule if more than 150–200 mg/dLReschedule if more than 200 mg/dL
    Duration of emission scan per bed positionNot mentionedTypically 5 min per bed positionUse manufacturer recommendations2–7 min
    CT techniqueNot mentioned30 mAs or lessTechnique is specific to each trialVariable and center-specific
    Reconstruction algorithmsNo specific recommendationsSpecific for GE, Siemens, and PhillipsUse manufacturer recommendations2D OSEM, 2 iterations. 20–30 subsets
    How to handle diabetic patientsScan in morning after overnight fast and before first use of medicationSpecific recommendations for type I and type II *Scheduled in morning with instructions provided in consultation with primary physicianWide variation, as described in text
    • ↵* Type I: Study will be scheduled preferably at end of morning; patient will have normal breakfast at 7:00 AM and use regular dose of insulin, followed by fasting for at least 4 h. Type II: Study will be scheduled preferably at end of morning; patient needs to have fasted for at least 4 h; intake of water is recommended; oral antidiabetic drugs should be continued.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (2)
Journal of Nuclear Medicine
Vol. 52, Issue 2
February 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Variations in PET/CT Methodology for Oncologic Imaging at U.S. Academic Medical Centers: An Imaging Response Assessment Team Survey
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Variations in PET/CT Methodology for Oncologic Imaging at U.S. Academic Medical Centers: An Imaging Response Assessment Team Survey
Michael M. Graham, Ramsey D. Badawi, Richard L. Wahl
Journal of Nuclear Medicine Feb 2011, 52 (2) 311-317; DOI: 10.2967/jnumed.109.074104

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Variations in PET/CT Methodology for Oncologic Imaging at U.S. Academic Medical Centers: An Imaging Response Assessment Team Survey
Michael M. Graham, Ramsey D. Badawi, Richard L. Wahl
Journal of Nuclear Medicine Feb 2011, 52 (2) 311-317; DOI: 10.2967/jnumed.109.074104
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Establishment of National DRL for CT in Hybrid Imaging Studies (The Second Phase of the National NM CT (PET) Dose Audit for Kuwait Population -2019)
  • SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0
  • Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network
  • Variability and Repeatability of Quantitative Uptake Metrics in 18F-FDG PET/CT of Non-Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction Protocol
  • Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT
  • Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial
  • Oncologic 18F-FDG PET/CT: Referring Physicians' Point of View
  • Introduction
  • Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments
  • Contribution of Imaging to Cancer Care Costs
  • Standardization of Quantitative Imaging: The Time Is Right, and 18F-FDG PET/CT Is a Good Place to Start
  • Google Scholar

More in this TOC Section

  • The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
  • SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association
  • Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center
Show more Special Contribution

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire